登陆
当前位置: 首页 >> 检索结果

结果排序

文献格式

出版时间

出版类型

出版语言
共有 4500 条符合本次的查询结果， 用时 2.7979428 秒

3381. Trial of Vancomycin and Cefazolin as Surgical Prophylaxis in Arthroplasty.

作者: Trisha N Peel.;Sarah Astbury.;Allen C Cheng.;David L Paterson.;Kirsty L Buising.;Tim Spelman.;An Tran-Duy.;Sam Adie.;Glenn Boyce.;Catherine McDougall.;Robert Molnar.;Jonathan Mulford.;Peter Rehfisch.;Michael Solomon.;Ross Crawford.;Tiffany Harris-Brown.;Janine Roney.;Jessica Wisniewski.;Richard de Steiger.; .
来源: N Engl J Med. 2023年389卷16期1488-1498页
The addition of vancomycin to beta-lactam prophylaxis in arthroplasty may reduce surgical-site infections; however, the efficacy and safety are unclear.

3382. Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer.

作者: Stephen J Freedland.;Murilo de Almeida Luz.;Ugo De Giorgi.;Martin Gleave.;Geoffrey T Gotto.;Christopher M Pieczonka.;Gabriel P Haas.;Choung-Soo Kim.;Miguel Ramirez-Backhaus.;Antti Rannikko.;Jamal Tarazi.;Swetha Sridharan.;Jennifer Sugg.;Yiyun Tang.;Ronald F Tutrone.;Balaji Venugopal.;Arnauld Villers.;Henry H Woo.;Fabian Zohren.;Neal D Shore.; .
来源: N Engl J Med. 2023年389卷16期1453-1465页
Patients with prostate cancer who have high-risk biochemical recurrence have an increased risk of progression. The efficacy and safety of enzalutamide plus androgen-deprivation therapy and enzalutamide monotherapy, as compared with androgen-deprivation therapy alone, are unknown.

3383. Type 2 Diabetes - Controlling the Epidemic, Episode 4: Understanding Old and New Therapies for Diabetes.

作者: E Dale Abel.;Julie R Ingelfinger.;Suyanna Linhales Barker.;Monica Peek.;Jane E B Reusch.;Clifford J Rosen.
来源: N Engl J Med. 2023年389卷16期e31页

3384. Venous Thoracic Outlet Syndrome.

作者: Sang Jun Park.;Hyun Jin Cho.
来源: N Engl J Med. 2023年389卷16期e32页

3385. Yellow Jack's Potential Return to the American South.

作者: Peter J Hotez.;Angelle Desiree LaBeaud.
来源: N Engl J Med. 2023年389卷16期1445-1447页

3386. A Chance to Modernize Health Care behind Bars - Section 1115 Medicaid Inmate Exclusion Waivers.

作者: Brendan Saloner.
来源: N Engl J Med. 2023年389卷16期1449-1451页

3387. Wedding Websites, Free Speech, and Adverse Drug Effects.

作者: Jerry Avorn.
来源: N Engl J Med. 2023年389卷16期1447-1449页

3388. Hepatitis D Virus Infection.

来源: N Engl J Med. 2023年389卷15期1444页

3389. Artificial Intelligence in U.S. Health Care Delivery. Reply.

作者: Nikhil R Sahni.;Brandon Carrus.
来源: N Engl J Med. 2023年389卷15期1443页

3390. Artificial Intelligence in U.S. Health Care Delivery.

作者: Yi-Chun Chen.;Hsiu-Yin Chiang.;Chin-Chi Kuo.
来源: N Engl J Med. 2023年389卷15期1442-1443页

3391. Artificial Intelligence in U.S. Health Care Delivery.

作者: Michael S Broder.
来源: N Engl J Med. 2023年389卷15期1442页

3392. Hepatitis D Virus Infection. Reply.

作者: Mario Rizzetto.
来源: N Engl J Med. 2023年389卷15期1441-1442页

3393. Hepatitis D Virus Infection.

作者: Shang-Chin Huang.;Jia-Horng Kao.
来源: N Engl J Med. 2023年389卷15期1441页

3394. Vaccine Effectiveness against Mpox in the United States. Reply.

作者: Nicholas P Deputy.;Jacqueline L Gerhart.;Leora R Feldstein.
来源: N Engl J Med. 2023年389卷15期1440-1441页

3395. Vaccine Effectiveness against Mpox in the United States.

作者: Ronen Arbel.;Roy Zucker.;Yael Wolff-Sagy.
来源: N Engl J Med. 2023年389卷15期1440页

3396. Zilebesiran for Hypertension. Reply.

作者: Akshay S Desai.;Marianne T Sweetser.;George L Bakris.
来源: N Engl J Med. 2023年389卷15期1439-1440页

3397. Zilebesiran for Hypertension.

作者: Daan J L van Twist.;Haris Kalic.
来源: N Engl J Med. 2023年389卷15期1438-1439页

3398. Zilebesiran for Hypertension.

作者: Meyer Lifschitz.
来源: N Engl J Med. 2023年389卷15期1438页

3399. Zilebesiran for Hypertension.

作者: Daria Abasheva.;Beatriz Fernandez-Fernandez.;Alberto Ortiz.
来源: N Engl J Med. 2023年389卷15期1438页

3400. Genetic Basis of Relapse after GPRC5D-Targeted CAR T Cells.

作者: Xiaoli Mi.;Alex Penson.;Omar Abdel-Wahab.;Sham Mailankody.
来源: N Engl J Med. 2023年389卷15期1435-1437页
共有 4500 条符合本次的查询结果， 用时 2.7979428 秒